Search

Robin P Enever

from Emmaus, PA
Age ~82
Get Report
Also known as:
Robin Elinor Enever, Robin N Enever, Rovin P Enever
Related to:
Brian Peterson, 56Donna Elston, 78Christopher Lynn, 32Kristin LynnJohn Lynn, 41
Connected to:
Howard H Enevold, 86Joann R Enevoldsen, 92Margaret Enevoldsen, 69Robin L Enevoldsen, 59Sean M Enevold, 41Susan K Enevold, 61Cathrine M Eney, 46Todd W Eney, 47Sharon M Enfante, 71Nicholas E Enfantino, 34

Robin Enever Phones & Addresses

  • Emmaus, PA
  • 1 Leeland Ct, New City, NY 10956 (845) 634-1258
  • 18 Pine St, Rouses Point, NY 12979 (518) 297-2751
  • Lehighton, PA

Work

Company: Pfizer Jan 1997 Position: Vice president, pharmaceutical sciences retired

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of London, United Kingdom 1964 to 1967 Specialities: Philosophy

Skills

Drug Delivery Systems • Biopharmaceutics • Pharmaceutical Technology • Clinical Development • Formulation • Drug Delivery • Drug Development • Regulatory Submissions • Regulatory Affairs • Hplc • Gmp • Pharmacology • Pharmaceutics • Fda • Pharmaceutical Industry • Pharmacovigilance • Drug Discovery • Technology Transfer

Industries

Pharmaceuticals

Resumes

Resumes

Robin Enever Photo 1

Robin Enever

View page
Location:
18 Pine St, Rouses Point, NY 12979
Industry:
Pharmaceuticals
Work:
Pfizer
Vice President, Pharmaceutical Sciences Retired
University of Minnesota Oct 1979 - Mar 1983
Associate Professor
The School of Pharmacy, University of London 1973 - 1979
Senior Lecturer
College of Pharmacy University of Kansas Feb 1975 - Sep 1975
Visiting Associate Professor and Fulbright-Hays Senior Scholar
Chelsea College University of London Oct 1967 - Sep 1973
Lecturer In Pharmaceutics
Education:
University of London, United Kingdom 1964 - 1967
Doctorates, Doctor of Philosophy, Philosophy University of London, United Kingdom 1961 - 1964
Bachelors, Bachelor of Pharmacy, Pharmacy
Skills:
Drug Delivery Systems
Biopharmaceutics
Pharmaceutical Technology
Clinical Development
Formulation
Drug Delivery
Drug Development
Regulatory Submissions
Regulatory Affairs
Hplc
Gmp
Pharmacology
Pharmaceutics
Fda
Pharmaceutical Industry
Pharmacovigilance
Drug Discovery
Technology Transfer

Publications

Us Patents

Hydroxyesters Of 7-Desmethylrapamycin

View page
US Patent:
6399626, Jun 4, 2002
Filed:
Sep 19, 2001
Appl. No.:
09/955685
Inventors:
Tianmin Zhu - Monroe NY
Robin Enever - New City NY
Assignee:
Wyeth - Madison NJ
International Classification:
C07D49116
US Classification:
514291, 540456
Abstract:
This invention provides hydroxyesters of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.

Ethers Of 7-Desmethlrapamycin

View page
US Patent:
6440991, Aug 27, 2002
Filed:
Sep 19, 2001
Appl. No.:
09/956322
Inventors:
Tianmin Zhu - Monroe NY
Robin Enever - New City NY
Assignee:
Wyeth - Madison NJ
International Classification:
C07D49116
US Classification:
514291, 540456
Abstract:
This invention provides ethers of 7-desmethylrapamycin which are useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.

Sugar Coatings And Methods Therefor

View page
US Patent:
20080107780, May 8, 2008
Filed:
Nov 5, 2007
Appl. No.:
11/935114
Inventors:
John KRESEVIC - New Windsor NY, US
Sheetal KULKARNI - Haskell NJ, US
Xiuying LIU - Glen Rock NJ, US
Nizamuddin BAKSH - Paramus NJ, US
Robin ENEVER - New City NY, US
Assignee:
WYETH - Madison NJ
International Classification:
A61K 9/36
A23G 3/50
US Classification:
426103, 426293, 426654
Abstract:
The invention provides sugar-containing compositions suitable for use in coating solid preparations such as tablets, pills, granules and grains. Methods of using such coatings are provided, as are solid dosage forms coated with the compositions. In some embodiments, the methods provide sugar coated tablets comprising conjugated estrogens, and a progestin, for example medroxyprogesterone acetate.

Estrogen/Serm And Estrogen/Progestin Bi-Layer Tablets

View page
US Patent:
20080175905, Jul 24, 2008
Filed:
Nov 28, 2007
Appl. No.:
11/946586
Inventors:
Xiuying Liu - Glen Rock NJ, US
John Kresevic - New Windsor NY, US
Nizamuddin Baksh - South Hackensack NJ, US
Robin Enever - New City NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 9/20
A61K 31/56
A61P 5/24
US Classification:
424464, 514169, 514177
Abstract:
The present invention is directed to bi-layer tablets comprising at least one estrogen in a first layer and a therapeutic agent in a second layer, and processes for their preparation.

Tablet-In-Tablet Compositions

View page
US Patent:
20080175908, Jul 24, 2008
Filed:
Jan 11, 2008
Appl. No.:
12/013109
Inventors:
Xiuying Liu - Glen Rock NJ, US
John Kresevic - New Windsor NY, US
Nizamuddin Baksh - South Hackensack NJ, US
Robin Enever - New City NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 9/28
A61K 31/565
US Classification:
424465, 514182, 514170
Abstract:
The present invention is directed to tablet-in-tablet compositions comprising one or more estrogens in a first layer and a therapeutic agent in a second layer, and processes for their preparation

Sugar-Coating Process And Baffles Therefor

View page
US Patent:
20080286439, Nov 20, 2008
Filed:
Nov 5, 2007
Appl. No.:
11/935092
Inventors:
Xiuying LIU - Glen Rock NJ, US
Nizamuddin BAKSH - Paramus NJ, US
Sheetal KULKARNI - Haskell NJ, US
John KRESEVIC - New Windsor NY, US
Robin ENEVER - New City NY, US
Assignee:
WYETH - Madison NJ
International Classification:
B01J 13/22
A23G 3/26
US Classification:
427 218, 118 19
Abstract:
This invention provides baffles () for use in coating pans () within coating apparatus, and methods of manufacturing the baffles (). The invention further provides methods of coating pharmaceutical formulations using the baffles () and coating pans () of the present invention.

Rapamycin Formulation For Iv Injection

View page
US Patent:
55300065, Jun 25, 1996
Filed:
Mar 7, 1994
Appl. No.:
8/207325
Inventors:
Robert P. Waranis - Chazy NY
Maureen M. Harrison - St. Albans VT
Thomas W. Leonard - Plattsburgh NY
Robin P. Enever - Rouses Point NY
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 3144
US Classification:
514291
Abstract:
Disclosed herein is an aqueous, injectable rapamycin solution comprising 0. 1 to 10 percent of a concentrate solution of rapamycin in N,N-dimethylacetamide, at concentrations of rapamycin ranging from 0. 25 mg/ml to 100 mg/ml, in combination with a diluent solution consisting of 0. 1 to 10 weight percent of one or more polyoxyethylene sorbitan esters, 10 to 60 weight percent of either polyethylene glycol 200 or 300 or both and 30 to 90 volume percent water, wherein the concentration of rapamycin in he combined solution ranges from 0. 05 mg/ml to 5. 0 mg/ml. Also disclosed is an aqueous, injectable solution of rapamycin, said solution comprising rapamycin in 0. 1 to 10 weight percent N,N-dimethylacetamide, 0. 09 to 7. 5 weight percent of one or more polyoxyethylene sorbitan esters, 9 to 60 weight percent of either polyethylene glycol 200 or 300 or both and 30 to 90 volume percent of water, wherein the concentration of rapamycin in the solution ranges from 0. 05 mg/ml to 5. 0 mg/ml.

Insulin Administration Using Methyl And Propyl Paraben

View page
US Patent:
47896604, Dec 6, 1988
Filed:
Sep 10, 1987
Appl. No.:
7/095292
Inventors:
Robin P. Enever - Rouses Point NY
Thomas W. Leonard - Plattsburgh NY
Karol K. Mikula - Morrisonville NY
Assignee:
American Home Products Corporation - New York NY
International Classification:
C07K 740
A61K 3726
US Classification:
514 4
Abstract:
A therapeutic composition for trans-mucosal administration in the treatment of diabetes including insulin, as an adjuvant a water-soluble fusidic acid salt and as a co-adjuvant methylparaben and/or propylparaben.
Control profile
Robin P Enever from Emmaus, PA, age ~82 Get Report